Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163618
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-09-08
Brief Title:
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx 3 Years After a Booster Vaccination With FSME-IMMUN 025 mL JUNIOR in Children
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approx 3 Years After a Booster Vaccination With FSME-IMMUN 025 mL JUNIOR in Children
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the TBE antibody persistence approximately three years after administration of a TBE booster vaccination with FSME-IMMUN 025 ml Junior in children who received either 025 mL or 05 mL TicoVac for their primary vaccination series in Study 146A
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None